Legend Biotech Corp - COMMON STOCK (LEGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
LEGN on Nasdaq
Shares outstanding
367,291,225
Price per share
$21.74
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
83,685,243
Total reported value
$2,727,887,108
% of total 13F portfolios
0%
Share change
-1,209,855
Value change
-$49,026,070
Number of holders
198
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Legend Biotech Corp - COMMON STOCK (LEGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +7.9% $1,796,605,025 +$133,409,532 55,093,684 +8% FMR LLC 30 Sep 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.7% $233,379,028 6,808,023 T. Rowe Price Associates, Inc. 31 Dec 2024

As of 30 Sep 2025, 198 institutional investors reported holding 83,685,243 shares of Legend Biotech Corp - COMMON STOCK (LEGN). This represents 23% of the company’s total 367,291,225 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Legend Biotech Corp - COMMON STOCK (LEGN) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 7.5% 27,702,842 +7.9% 0.05% $903,389,672
WESTFIELD CAPITAL MANAGEMENT CO LP 1.7% 6,094,486 -5.8% 0.83% $198,741,180
HHLR ADVISORS, LTD. 1.6% 5,984,550 0% 4.8% $195,156,176
BlackRock, Inc. 1.2% 4,494,623 +5.8% 0% $146,569,648
SUVRETTA CAPITAL MANAGEMENT, LLC 1% 3,818,009 +1.2% 3.8% $124,505,273
DEERFIELD MANAGEMENT COMPANY, L.P. 0.81% 2,962,338 0% 1.5% $96,601,842
Artisan Partners Limited Partnership 0.69% 2,547,952 +20% 0.12% $83,088,715
JANUS HENDERSON GROUP PLC 0.58% 2,125,085 +1.5% 0.03% $69,293,319
BRAIDWELL LP 0.5% 1,826,155 -28% 1.8% $59,550,915
ALLIANCEBERNSTEIN L.P. 0.44% 1,632,967 +4.6% 0.02% $53,251,054
STATE STREET CORP 0.32% 1,157,122 +3.3% 0% $37,733,748
FEDERATED HERMES, INC. 0.29% 1,065,303 +0.15% 0.06% $34,739,531
GOLDMAN SACHS GROUP INC 0.29% 1,055,486 +12% 0% $34,419,398
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 0.28% 1,028,447 -20% 7.8% $33,537,657
UBS Group AG 0.28% 1,010,859 -1% 0.01% $32,964,113
Capital International Investors 0.26% 941,600 -13% 0% $30,705,576
ArrowMark Colorado Holdings LLC 0.26% 938,678 -4.6% 0.57% $30,610,290
IvyRock Asset Management (HK) Ltd 0.23% 856,900 -1.5% 12% $27,943,509
RENAISSANCE TECHNOLOGIES LLC 0.23% 843,200 +28% 0.04% $27,496,752
TANG CAPITAL MANAGEMENT LLC 0.23% 830,000 0% 1% $27,066,300
JOHNSON & JOHNSON 0.22% 814,586 0% 5.3% $26,563,649
MILLENNIUM MANAGEMENT LLC 0.22% 792,485 +7% 0.02% $25,842,936
TWO SIGMA ADVISERS, LP 0.2% 723,700 +1.1% 0.05% $23,599,857
AMERIPRISE FINANCIAL INC 0.15% 542,322 -14% 0% $17,685,120
GEODE CAPITAL MANAGEMENT, LLC 0.15% 540,042 +14% 0% $17,462,097

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,026,952 $22,323,546 +$4,383,549 $21.74 13
2025 Q3 83,685,243 $2,727,887,108 -$49,026,070 $32.61 198
2025 Q2 84,637,633 $3,002,800,929 -$25,701,898 $35.49 209
2025 Q1 85,585,612 $2,906,390,112 -$451,293,431 $33.93 205
2024 Q4 99,259,008 $3,230,144,565 +$188,311,867 $32.54 205
2024 Q3 91,083,902 $4,438,353,408 +$43,810,918 $48.73 204
2024 Q2 91,534,759 $4,053,943,715 +$152,693,975 $44.29 173
2024 Q1 86,480,093 $4,850,469,897 +$24,114,634 $56.09 187
2023 Q4 85,815,138 $5,163,245,741 -$85,151,940 $60.17 204
2023 Q3 85,989,090 $5,775,420,098 +$112,052,258 $67.17 198
2023 Q2 84,064,242 $5,802,906,378 +$1,140,343,215 $69.03 191
2023 Q1 68,026,089 $3,279,762,243 +$214,876,512 $48.22 158
2022 Q4 63,494,614 $3,169,508,515 -$28,958,118 $49.92 167
2022 Q3 63,810,382 $2,603,349,501 +$399,712,134 $40.80 154
2022 Q2 52,707,652 $2,898,825,468 +$118,361,366 $55.00 147
2022 Q1 51,010,221 $1,853,796,102 +$18,669,383 $36.34 137
2021 Q4 50,201,932 $2,340,358,513 +$500,109,001 $46.61 137
2021 Q3 39,005,848 $1,971,657,000 +$572,564,727 $50.56 87
2021 Q2 28,328,593 $1,162,838,000 +$121,639,656 $41.05 84
2021 Q1 26,391,052 $765,864,420 +$30,109,528 $29.02 69
2020 Q4 25,444,505 $716,732,000 +$16,894,703 $28.16 60
2020 Q3 24,479,702 $752,680,000 -$30,044,903 $30.87 50
2020 Q2 24,613,241 $1,036,097,000 +$1,036,097,000 $42.56 76